Theriva Biologics (TOVX) Q3 2025 Earnings

11AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-7.22
-2.8
1.61
6.03

Details

Expected EPS
-0.775
Actual EPS
-1.93
Surprise EPS
-1.15
Surprise Percent
+149.03%

Description

Theriva Biologics (TOVX) has reported earnings of -1.93 per share for Q3 2025.

0 Comments

Share your thoughts